Under this context, irisin was rapidly postulated to be beneficial in the treatment of obesity, diabetes, and a wide range of pathological conditions characterized by a variable imbalance of energy demand and expenditure [4, 9–13]. The gene discussed is FNDC5; the disease is obesity due to melanocortin 4 receptor deficiency.